B. Termander

Prednimustine (Sterecyt) versus cyclophosphamide both in combination with methotrexate and 5-fluorouracil in the treatment of advanced breast cancer.

B. Nilsson, H. Yosef, A. Slater, 1993, European journal of cancer.

Prognostic significance of glucocorticoid receptor determination in patients with chronic lymphocytic leukemia and immunocytoma--lack of a positive correlation between receptor levels and clinical responsiveness.

T. Lipp, E. Thiel, R. Herrmann, 1990, Leukemia research.

Effect of urinary pH on the plasma and urinary kinetics of remoxipride in man

E. Widerlöv, M. Nilsson, B. Termander, 2004, European Journal of Clinical Pharmacology.

The first clinical pilot study of roquinimex (Linomide) in cancer patients with special focus on immunological effects.

J. Bergh, T. Tötterman, B. Nilsson, 1997, Cancer investigation.

Continuous versus intermittent prednimustine treatment of non-hodgkin’s lymphoma

L. Baldetorp, J. Carstensen, T. Möller, 1993, Medical oncology and tumor pharmacotherapy.

Stimulation of NK cell, T cell, and monocyte functions by the novel immunomodulator Linomide after autologous bone marrow transplantation. A pilot study in patients with acute myeloid leukemia.

B. Simonsson, B. Smedmyr, M. Bengtsson, 1992, Transplantation.

Clinical pilot study of roquinimex (Linomide®) in patients with autoimmune disease

O. Nived, G. Sturfelt, B. Nilsson, 1994 .